Grail (GRAL) Competitors $25.93 +1.08 (+4.35%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$25.62 -0.31 (-1.18%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. BTSG, SHC, SGRY, PRVA, CON, LFST, WGS, VCYT, PGNY, and ADUSShould you be buying Grail stock or one of its competitors? The main competitors of Grail include BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), GeneDx (WGS), Veracyte (VCYT), Progyny (PGNY), and Addus HomeCare (ADUS). These companies are all part of the "healthcare" industry. Grail vs. BrightSpring Health Services Sotera Health Surgery Partners Privia Health Group Concentra Group Holdings Parent LifeStance Health Group GeneDx Veracyte Progyny Addus HomeCare BrightSpring Health Services (NASDAQ:BTSG) and Grail (NASDAQ:GRAL) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations. Which has preferable earnings and valuation, BTSG or GRAL? Grail has lower revenue, but higher earnings than BrightSpring Health Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrightSpring Health Services$11.27B0.27-$154.60M-$0.12-142.33Grail$125.60M7.00N/AN/AN/A Do analysts rate BTSG or GRAL? BrightSpring Health Services presently has a consensus price target of $21.67, indicating a potential upside of 26.85%. Grail has a consensus price target of $20.00, indicating a potential downside of 22.87%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, research analysts clearly believe BrightSpring Health Services is more favorable than Grail.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BrightSpring Health Services 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90Grail 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media refer more to BTSG or GRAL? In the previous week, Grail had 4 more articles in the media than BrightSpring Health Services. MarketBeat recorded 13 mentions for Grail and 9 mentions for BrightSpring Health Services. Grail's average media sentiment score of 1.38 beat BrightSpring Health Services' score of 1.13 indicating that Grail is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Grail 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is BTSG or GRAL more profitable? Grail has a net margin of 0.00% compared to BrightSpring Health Services' net margin of -0.38%. BrightSpring Health Services' return on equity of 4.16% beat Grail's return on equity.Company Net Margins Return on Equity Return on Assets BrightSpring Health Services-0.38% 4.16% 0.99% Grail N/A N/A N/A Does the MarketBeat Community prefer BTSG or GRAL? BrightSpring Health Services received 26 more outperform votes than Grail when rated by MarketBeat users. Likewise, 89.66% of users gave BrightSpring Health Services an outperform vote while only 0.00% of users gave Grail an outperform vote. CompanyUnderperformOutperformBrightSpring Health ServicesOutperform Votes2689.66% Underperform Votes310.34%GrailOutperform VotesNo VotesUnderperform Votes4100.00% SummaryBrightSpring Health Services beats Grail on 8 of the 12 factors compared between the two stocks. Remove Ads Get Grail News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGrailMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$878.90M$2.86B$5.33B$7.57BDividend YieldN/A31.37%5.11%4.32%P/E RatioN/A13.3521.7217.82Price / Sales7.00187.75376.8894.61Price / CashN/A57.5638.1534.64Price / BookN/A4.556.474.00Net IncomeN/A-$22.21M$3.20B$247.23M7 Day Performance4.14%2.20%2.86%1.45%1 Month Performance-12.81%-1.18%-8.55%-6.24%1 Year PerformanceN/A8.11%10.58%0.60% Grail Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGrail0.5781 of 5 stars$25.93+4.3%$20.00-22.9%N/A$878.90M$125.60M0.001,360Short Interest ↑News CoveragePositive NewsGap DownBTSGBrightSpring Health Services2.9237 of 5 stars$17.28+0.8%$21.67+25.4%+64.4%$3.02B$11.27B-66.4635,000News CoverageGap DownSHCSotera Health2.4134 of 5 stars$10.23-1.1%$16.00+56.4%-4.6%$2.90B$1.10B40.923,000Gap DownSGRYSurgery Partners2.7624 of 5 stars$20.51-2.8%$36.63+78.6%-17.9%$2.62B$3.11B-42.7313,500Positive NewsGap DownPRVAPrivia Health Group3.7677 of 5 stars$21.48-2.2%$26.67+24.1%+31.8%$2.59B$1.74B214.82810Analyst ForecastHigh Trading VolumeCONConcentra Group Holdings ParentN/A$20.19-2.1%$28.50+41.2%N/A$2.57B$1.90B13.3711,000Positive NewsGap DownLFSTLifeStance Health Group1.9107 of 5 stars$6.51-2.0%$8.50+30.6%+16.6%$2.50B$1.25B-25.046,640Positive NewsGap DownWGSGeneDx1.8312 of 5 stars$84.77+5.9%$72.33-14.7%+934.6%$2.38B$305.45M-43.251,200Positive NewsVCYTVeracyte4.0071 of 5 stars$29.53+2.0%$43.40+47.0%+64.0%$2.30B$445.76M-196.87790Short Interest ↑PGNYProgyny1.5644 of 5 stars$21.43-5.2%$23.64+10.3%-35.5%$1.83B$1.17B36.95310Short Interest ↓Positive NewsADUSAddus HomeCare4.5855 of 5 stars$97.00-3.3%$132.78+36.9%+2.6%$1.76B$1.15B22.2033,200Positive NewsHigh Trading Volume Remove Ads Related Companies and Tools Related Companies BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives LifeStance Health Group Alternatives GeneDx Alternatives Veracyte Alternatives Progyny Alternatives Addus HomeCare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grail, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GRAL Stock Free GRAL Stock Alerts